<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Using microRNA (miRNA) expression array, we identified that miR-7 was deregulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the biological role and molecular target of miR-7 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>miR-7 was downregulated in six out of seven <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>Ectopic expression of miR-7 suppressed <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell proliferation (P&lt;0.05), induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (P&lt;0.05) and caused cell-cycle arrest in G1 phase (P&lt;0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressive function of miR-7 was further confirmed in <z:mp ids='MP_0003815'>nude</z:mp> mice (P&lt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>The 3'-untranslated region (3'UTR) of Yin Yang 1 (YY1) <z:chebi fb="2" ids="33699">mRNA</z:chebi> contains an evolutionarily conserved miR-7 binding site using in silico searches, luciferase reporter assay and western blot analysis confirmed that miR-7 directly bound to YY1 3'UTR to negatively regulate the protein expression of YY1 in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines HCT116 and LOVO </plain></SENT>
<SENT sid="6" pm="."><plain>Intriguingly, knock-down of YY1 in three <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines (HCT116, LOVO and DLD1) consistently suppressed cell proliferation (P&lt;0.01) and induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (P&lt;0.01), indicating the opposite functions of miR-7 and YY1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Consistent with these data, ectopic expression of YY1 promoted cell growth by increasing proliferation (P&lt;0.01) and suppressing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (P&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>The tumorigenic ability of YY1 was further confirmed in vivo in xenograft-<z:mp ids='MP_0003815'>nude</z:mp> mouse model (P&lt;0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, pathway analyses revealed that the oncogenic effect by YY1 was associated with inhibiting p53 and modulating its downstream effectors p15, caspase cascades and C-Jun, and activating Wnt signaling pathway through activating Î²-catenin, anti-apoptotic survivin and fibroblast growth factor 4 </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, multivariate analysis revealed that patients with YY1 protein high expression had a significant decrease in overall survival, and Kaplan-Meier survival curves showed that these patients had significantly shorter survival than others (P&lt;0.0001) </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, MiR-7 is a novel miRNA with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressive function in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> by targeting oncogenic YY1 </plain></SENT>
<SENT sid="12" pm="."><plain>YY1 promotes <z:hpo ids='HP_0003003'>colon cancer</z:hpo> growth through inhibiting p53 and promoting Wnt signaling pathways and serves as an independent prognostic biomarker for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients.Oncogene advance online publication, 3 December 2012; doi:10.1038/onc.2012.526 </plain></SENT>
</text></document>